EXOMERE エクソソーム エクソミア サロン専売品 サロン物販 ファンデーション リカバリーバーム 受賞 日焼け止め 韓国コスメ

Time72 EXOMERE wins two prestigious awards in Korea

Time72 EXOMEREが韓国の権威ある賞をダブル受賞

[Good news] EXOMERE received two major awards in Korea✨

We are pleased to announce that our popular brand, Time72 EXOMERE, has received high praise in Korea and won two prestigious awards.

1. Ranked No. 1 in the Korea Consumer Satisfaction Index in 2025

In recognition of its innovative technology and high customer support, "Time72 EXOMERE" was awarded the No. 1 spot in the cosmetics (exosome) category of the "2025 Korea Consumer Satisfaction Index," sponsored by leading Korean media outlet "Money Today."

This award is based on direct consumer evaluation and satisfaction and is a testament to the product's quality and effectiveness, which is highly valued in the marketplace.

2. Selected as an outstanding product at the 2025 Seoul Awards

Furthermore, the flagship product, "Time 72 Exomia / Recovery Balm Plus," was selected as an outstanding product at the "2025 Seoul Awards" hosted by the Seoul Economic Promotion Agency (SBA).

The Seoul Award is given to products that have excellent competitiveness and high value. This selection officially recognizes the outstanding quality of Recovery Balm.

3. Introducing the excellent product "Recovery Balm Plus"

Time 72 Exomia Recovery Balm

This regenerative BB cream contains exosomes extracted from the organic Hallabong (Dekopon) fruit, a specialty of Jeju Island, and is fermented at low temperature for 72 hours. It provides UV protection with SPF 35 and PA++, as well as strengthening the skin barrier, improving wrinkles, and anti-inflammatory properties, and has been attracting a lot of attention from consumers since its release.

This recovery balm is currently experiencing a surge in popularity worldwide. Demand is so high that the manufacturer is unable to keep up with supply, and it often goes out of stock... Please purchase it while it's still in stock.

Leave a comment

Please note, comments need to be approved before they are published.

Related Columns

This is also popular